...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion

Hi there

I do not write here offently but i read almost evething.

FYI this the naming at my RBC account, since the beginning at the split i think in 2013.

Share
New Message
Please login to post a reply